OI Shareholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against O-I Glass, Inc.

Robbins LLP has filed class action lawsuits against O-I Glass, Inc. for misleading investors about its 2026 financial outlook and Fit to Win program, Everest Group, Ltd. for aggressive expansion and false risk management assurances, and Tenax Therapeutics, Inc. for misrepresenting the viability of its drug candidate levosimendan. O-I Glass stock declined 15% after the company reduced its 2026 guidance on July 29, 2026.